Buradasınız

Anasayfa » Content

Travma sonrası stres bozukluğu hastalarında gece idrar noradrenalin düzeyleri ve uyku yapısı

Nocturnal levels of urinary noradrenaline and sleep structure in patients with post-traumatic stress disorder

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2010

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Noradrenergic system is one of the major central nervous system effectors of the human stress response. The studies suggest that the patients with post-traumatic stress disorder have hyperreactive noradrenergic systems, and this exaggerated noradrenergic activity is associated with a number of hyperarousal symptoms in post-traumatic stress disorder. Central noradrenergic system also has a role in the regulation of arousal state during sleep. In this study, it was therefore aimed to investigate the relationship between nocturnal urinary levels of noradrenaline and sleep variables. Fourteen patients with chronic post-traumatic stress disorder and 12 age- and sex-matched healthy normal controls were investigated with polysomnographic recordings on two consecutive nights. Urine samples were collected for 24 hours in three 8-hour collections following the adaptation night in the sleep laboratory. Patients with post-traumatic stress disorder had difficulty in initiating sleep, poor sleep efficiency, decreased total sleep time, decreased slow wave sleep, and a reduced rapid eye movement sleep latency when compared to the normal controls. There was not any correlation between nocturnal urinary noradrenaline values and sleep variables. This study did not demonstrate any significant relationship between urinary noradrenaline levels and disturbed sleep measures in patients with posttraumatic stress disorder.
Bookmark/Search this post with
Abstract (Original Language): 
Noradrenerjik sistem, stres cevabının önemli merkezi sinir sistemi yolaklarından birisidir. Çalışmalar travma sonrası stres bozukluğu hastalarında noradrenerjik sistemin aşırı aktivite gösterdiğini ve bu aşırı noradrenerjik aktivitenin aşırı uyarılmışlık bulguları ile ilişkili olduğunu desteklemektedir. Merkezi noradrenerjik sistem aynı zamanda uykuda uyarılmışlığın düzenlenmesinde rol alır. Çalışmada, bu nedenle gece idrar noradrenalin ölçümleri ile uyku de- ğişkenleri arasındaki ilişkiyi araştırmak amaçlanmıştır. On dört kronik travma sonrası stres bozukluğu hastası ile yaş ve cinsiyet yönünden eşleştirilmiş 12 sağlıklı normal kontrol vakası ardışık 2 gece polisomnografi çalışması ile incelenmiştir. Adaptasyon gecesini takiben yirmi dört saatlik idrar sekizer saatlik kaplarla uyku laboratuvarında toplanmıştır. Normal kontrol grubu ile karşılaştırıldığında travma sonrası stres bozukluğu hastalarında uykuya baş- lamakta güçlük, uyku etkinliğinde, toplam uyku süresinde, yavaş dalga uykusunda azalma ve REM uyku latensinde azalma gözlendi. Uyku değişkenleri ile gece idrar noradrenalin düzeyleri arasındaki ilişki incelendiğinde ise herhangi bir bağıntı bulunmadı. Bu çalışmada travma sonrası stres bozukluğu hastalarında idrar örneklerinden alınan noradrenalin değerleri ile bozulmuş uyku değerleri arasında herhangi bir ilişki gösterilememiştir.
FULL TEXT (PDF): 
PDF icon arastirmax-travma-sonrasi-stres-bozuklugu-hastalarinda-gece-idrar-noradrenalin-duzeyleri-uyku-yapisi.pdf
  • 4
252-256
  • Turkish

REFERENCES

References: 

Kaynaklar
1. Amerikan Psikiyatri Birliği (1994) Mental Bozuklukların
Tanısal ve Sayımsal El Kitabı, Dördüncü Baskı (DSM-IVTR) (Çev.ed.: E Köroğlu) Hekimler Yayın Birliği, Ankara.
2. Redmond DE, Huang YH. New evidence for a locus
coerulous-norepinephrine connection with anxiety.
Life Sci 1979; 25: 2149-2162.
3. Ravindran LN, Stein MB. Pharmacotherapy of PTSD:
Premises, principles, and priorities. Brain Res 2009;
1293: 24-39.
4. Shin LM, Rauch SL, Pitman RK. Amygdala, medial
prefrontal cortex, and hippocampal function in PTSD.
Ann N Y Acad Sci 2006; 1071: 67-79.
5. Orr SP. Psychophysiologic reactivity to trauma-related
imagery in PTSD. Diagnostic and theoretical implications
of recent findings. In: Yehuda R, McFarlane AC (eds).
Psychobiology of Posttraumatic Stress Disorder. New
York: New York Academy of Sciences, 1997: 114-124.
6. Yehuda R, Southwick S, Giller EL, Xiaowan MA, Mason
JW. Urinary catecholamine excretion and severity of
PTSD symptoms in Vietnam combat veterans. J Nerv
Ment Dis 1992; 180: 321-325.
7. Yehuda R, Siever LJ, Teicher MH. Plasma norepinephrine
and 3-methoxy-4-hydroxyphenylglycol concentrations
and severity of depression in combat posttraumatic
stress disorder and major depressive disorder. Biol
Psychiatry 1998; 44: 56-63.
8. Geracioti TD, Baker DG, Ekhator NN, et al. CSF
norepinephrine concentrations in posttraumatic stress
disorder. Am J Psychiatry 2001; 158: 1227-1230.
9. Perry BD, Southwick SM, Yehuda R, Giller EL. Adrenergic
receptor regulation in posttraumatic stres disorder. In:
Giller EL (ed). Biological Assessment and Treatment
of Posttraumatic Stress Disorder. Washington, DC:
American Psychiatric Press, 1990: 87-114.
10. Southwick SM, Krystal JH, Morgan CA, et al. Abnormal
noradrenergic function in posttraumatic stress disorder.
Arch Gen Psychiatry 1993; 50: 266-274.
11. Southwick SM, Yehuda R, Morgan CA. Clinical studies
of neurotransmitter alterations in post-traumatic stress
disorder. In: Frieman MJ, Charney DS, Deutch AY (eds).
Neurobiological and Clinical Consequences of Stress.
Philadelphia: Lippincott-Raven, 1995: 335-349.
12. Rama AN, Cho SC, Kushida CA. Normal human sleep.
In: Teofili LC (ed). Sleep: A Comprehensive Handbook.
New Jersey: John Wiley & Sons, 2006: 3-9.
13. Mavanji V, Datta S. Sleep-wake effects of yohimbine
and atropine in rats with a clomipramine-based model
of depression. Neuroreport 2002; 13: 1603-1606.
14. Jones BE. From waking to sleeping: neuronal and
chemical substrates. Trends Pharmacol Sci 2005; 11:
578-586.
15. Lavie P, Hefez A, Halperin G, Enoch D. Long-term
effects of traumatic war-related events on sleep. Am J
Psychiatry 1979; 136: 175-178.
16. Hefez A, Metz L, Lavie P. Long-term effects of extreme
situational stress on sleep and dreaming. Am J Psychiatry
1987; 144: 344-347.
17. Mikulincer M, Glaubman H, Wasserman O, Porat A,
Birger M. Control-related beliefs and sleep characteristics
of posttraumatic stress disorder patients. Psychol Rep
1989; 65: 567-576.
18. Glaubman H, Mikulincer M, Porat A, Wasserman O,
Birger M. Sleep of chronic posttraumatic patients. J
Trauma Stress 1990; 3: 255-263.
19. Yetkin S, Aydın H, Özgen F. Polysomnography in
patients with post-traumatic stress disorder. Psychiatr
Clin Neurosci 2010; 64: 309-317.
20. Mellman TA, Kumar A, Kulic-Bell R, Kumar M, Nolan B.
Nocturnal/daytime urine noradrenergic measures and
sleep in combat-related PTSD. Biol Psychiatry 1995; 38:
174-179.
21. Spitzer RL, Williams JBW, Gibbon M. Structured
Clinical Interview for DSM-III-R (SCID). New York State
Psychiatric Institute, New York, NY, 1987.
22. Sorias S, Saygılı R, Elbi H, Nifirme Z, Mete L, Vahip S.
DSM-III-R Yapılandırılmış Klinik Görüşmesi (SCID)
Türkçe versiyonu: Retest ve kullanıcılar arası uyuşma ve
güvenirliğin araştırılması. Ege Üniversitesi Tıp Fakültesi
Dergisi 1989; 28: 2349-2356.
23. Blake DD, Weathers FW, Nagy LM, et al. The
development of a clinician administered PTSD scale. J
Trauma Stress 1995; 8: 75-90.
24. Aker AT, Özeren M, Başoğlu M, Kaptanoğlu C, Erol A,
Buran B. Clinician Administered Post Traumatic Stress
Disorder Scale (CAPS) reliability and validity study.
Turkish J Psychiatry 1999; 10: 286-293.
25. Williams BW. A structured interview guide for Hamilton
Depression Rating Scale. Arch Gen Psychiatry 1988; 45:
742-747.
26. Akdemir A, Örsel S, Dağ I, Türkçapar H, İşcan N,
Özbay H. Hamilton depresyon derecelendirme ölçeği
(HDDÖ)’nin geçerliği, güvenirliği ve klinikte kullanımı.
Psikiyatri Psikoloji Psikofarmakoloji Dergisi 1996; 4:
251-259.
27. Rechtschaffen A, Kales A. A Manual of Standardized
Terminology, Techniques and Scoring System for Sleep
Stages of Human Subjects. US Government Printing
Office, Washington DC, 168.
28. Ebert M, Kopin IJ. Differential labellings of urinary
catecholamine metabolites by dopamine-C14. Trans
Assoc Am Phys 1975; 28: 256-264.

Thank you for copying data from http://www.arastirmax.com